Showing 991-1000 of 4117 results for "".
Systemic Implications of Psoriasis
https://practicaldermatology.com/topics/psoriasis/systemic-implications-of-psoriasis/18636/Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfand, MD, talks about the increased risk for diabetes and cardiovascular disease in patients with psoriasis, as well as the clinician's role in educating patients about their diseaseCurrents
https://practicaldermatology.com/topics/practice-management/currents/21111/Body of Work: The Burgeoning Field of Body AestheticsJUVEDERM Voluma Mid-Cheek Injection Demo Video
https://practicaldermatology.com/topics/general-topics/juvederm-voluma-mid-cheek-injection-demo-video/18872/Watch Dr Sheila Barbarino perform a pain free cheek injection using Juvederm Voluma at her Hermosa Beach plastic surgery center, Barbarino Surgical Arts. Juvederm Voluma is the latest of the Juvederm range of hyaluronic acid fillers specifically designed to restore volume in areas of volume loss. Vo2014 Year in Review: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-skin-cancer/19001/Gary Goldenberg, MD offers a snapshot look at the newest therapies in the skin cancer treatment landscape, as well as the newest innovations across various disease states in the specialty.Customize Online Content to Suit Your Target Audience
https://practicaldermatology.com/topics/practice-management/customize-online-content-to-suit-your-target-audience/21256/You can generate maximum impact for your practice when you create customized content with a sharp focus on your target audience.Get in the Groove
https://practicaldermatology.com/topics/practice-management/get-in-the-groove/21255/Create habits to help you work smarter.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.Understanding Sublative Therapy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-sublative-therapy/19056/What is sublative? Michael H. Gold, MD explains how the technology works and how it fits in practice.Beware of International Injectables
https://practicaldermatology.com/topics/practice-management/beware-of-international-injectables/19053/Julie Woodward, MD. Associate Professor of Ophthalmology Associate Professor in Dermatology; Chief, Oculoplastic and Reconstructive Surgery Service, Duke University Medical Center, addresses the challenges that arise when patients receive unknown injectables overseas. Complications from improperly uInvesting in EHRs
https://practicaldermatology.com/topics/practice-management/investing-in-ehrs-/19051/Tim Sayed, MD talks about the role of electronic health records in the aesthetics practice. He talks about investing in the right system and knowing when and how to change course. He addresses the sunk cost fallacy.